Tag:
ViroChem
Latest Headlines
Latest Headlines
Vertex buys ViroChem in $375M in hep C deal
With its closely-watched hep C drug telaprevir working its way toward an FDA filing, Vertex Pharmaceuticals announced that it is buying Canada's ViroChem Pharma for $375 million in cash and stock.
